Progress towards rabies control.
Although safe and efficacious tissue-culture-derived rabies vaccines are available in developed countries, much of the world still depends on vaccines derived from neural tissue which were introduced half a century ago. Considerable advances have been made in our understanding of the molecular biology of rabies virus, and genetically engineered recombinant viruses (vaccinia-rabies virus glycoprotein) have been developed. These may facilitate the control of rabies in some species by oral vaccination campaigns.
Ferguson
M
M
Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Herts, UK.
D000818:Animals; D004333:Drug Administration Routes; D006801:Humans; D007114:Immunization; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000008:administration & dosage; D011820:Rabies virus / Q000648:ultrastructure; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000008:administration & dosage
D011819:Rabies Vaccines; D014614:Vaccines, Synthetic